Conference Day One: 16th February 2011

8:00 Registration & Refreshments

9:00 Chairman’s Welcome

Developing A Robust Yet Flexible Anti-Counterfeiting Strategy For The Modern Age To Ensure Patient Safety And Reduce Ipr Enforcement Costs

09:10 Back To Basics – A Holistic Perspective: Ensuring Your Product Is Secure With A Robust Anti-Counterfeiting Strategy

  • Setting up and implementing a successful global anticounterfeiting programme
  • Predicting and dealing with common pitfalls and challenges
  • Identifying business critical goals and incorporating these into your strategy
  • Case study: learning from recent real-world examples

Heike Bockholt
Senior Manager, Global Anti-Counterfeiting Strategy
Boehringer-Ingelheim

09:50 Case Study: Establishing A Secure Distribution System In A Pharmaceutical Manufacturer

  • Guarding the supply chain up to the dispensing points from infiltration and diversion
  • Ensuring product security with anti-tampering measures
  • Minimising risk by authenticating at multiple stages throughout the supply chain
  • Incorporating all these aspects of product security into a single, effective holistic strategy

Sebastien Mauel
Head of Product Security Strategy
Merck Serono

10:30 Networking Coffee Break

11:00 The Europol Contribution To The Fight Against Counterfeit Medicines

  • Assessing the threat of counterfeit medicines in Europe
  • Highlighting action taken by Europol including strategic and operational co-operation
  • Effective partnerships with the pharmaceutical industry and right holders
  • Looking to the future: the future considering new tools

Chris Vansteenkiste
IP Crime Project Manager
Europol

11:40 Ensuring Your Product Is Protected On All Fronts: Legislation And Cases From Dutch Customs

  • Highlighting transit cases and ECJ decisions
  • Assessing the problem of internet deliveries and small consignments
  • Reviewing the new legislation 1383/2003
  • Discussing the WTO complaint and generics

Peter Sannes
National Co-ordinator
Dutch Customs

12:20 The Changing Face Of Counterfeiting: A German Customs Perspective

  • Presenting an update on Project Blue
  • Reviewing the current situations in Germany and the Baltics
  • Discussing recent completed investigations and case studies
  • Working effectively together with customs to enforce IP rights

Dirk Schaub
IP Crime Investigator
German Customs

13:00 Networking Lunch Break

14:20 Case Study: Fighting Counterfeiting Online: Successes And Best Practices

  • Assessing the extent of the problem and new trends today
  • Discussing real-world examples of success stories and best practices
  • Co-operating with law enforcement and organisations to ensure effective protection and prevention
  • Looking at what needs to be done for future security

David Shore
Director Global Security Europe
Pfizer

Monitoring And Protecting The Legitimate Supply Chain To Ensure It Is Not Compromised By Counterfeit Drugs

15:00 Is Diversion The New Counterfeiting: Protecting Your Product Integrity And Revenue Streams From The Fight On Another Front

  • Identifying diversion as a bigger problem than counterfeiting
  • Assessing the lucrative nature and relative ease of diversion vs. counterfeiting
  • Highlighting how diversion can be used to disguise counterfeiting operations in tandem
  • Addressing these issues – how can we solve this new problem?

John Franks
Security Director EMEA
Merck Sharp & Dohme

15:40 Networking Coffee Break

16:10 Using And Securing The Supply Chain To Maintain Product Integrity

  • Highlighting how choice of transport mode affects security of supply
  • Discussing how choice of provider affects security of supply
  • Assessing what safeguards already exist in the supply chain
  • Evaluating where the weak points are and how can these be addressed

Mark Edwards
Global Freight Manager
Actavis

16:50 The Pharmacy Perspective: Making Pharmacy-Level Authentication A Reality In Europe

  • Introducing the PGEU’s policy on counterfeit medicines
  • Reviewing possible models for pharmacy level authentication
  • Discussing key issues from a pharmacy perspective
  • Moving from vision to reality: the next steps

John Chave
Secretary General
PGEU

17:30 Chairman’s Closing Comments And Close Of Day 1